Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges, Nat Rev Rheumatol, vol.11, issue.5, pp.276-89, 2015. ,
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis, Ann Rheum Dis, vol.73, issue.3, pp.516-544, 2014. ,
Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70, Biologics, vol.6, pp.429-64, 2012. ,
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis, Ann Rheum Dis, vol.73, issue.3, pp.529-564, 2014. ,
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview, CMAJ, vol.181, issue.11, pp.787-96, 2009. ,
Adverse effects of biologics: a network meta-analysis and Cochrane overview, Cochrane Database Syst Rev, vol.2, p.8794, 2011. ,
Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis, Joint Bone Spine, vol.81, issue.4, pp.287-97, 2014. ,
American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis, Arthritis Care Res (Hoboken), vol.64, issue.5, pp.625-664, 2008. ,
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force, Ann Rheum Dis, vol.75, issue.1, pp.3-15, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01890959
Stromal gene signatures in large-B-cell lymphomas, N Engl J Med, vol.359, issue.22, pp.2313-2336, 2008. ,
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts, N Engl J Med, vol.369, issue.1, pp.20-31, 2013. ,
Clinical evidence supporting genomic tests in early breast cancer: do all genomic tests provide the same information?, Eur J Surg Oncol, vol.43, pp.909-929, 2017. ,
Gene expression analysis in RA: towards personalized medicine, Pharmacogenomics J, vol.14, issue.2, pp.93-106, 2014. ,
Moving towards personalized medicine in rheumatoid arthritis, Arthritis Res Ther, vol.16, issue.3, p.110, 2014. ,
Does gene expression analysis inform us in rheumatoid arthritis?, Ann Rheum Dis, vol.69, issue.1, pp.37-42, 2010. ,
Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study, Mol Med, vol.22, pp.322-330, 2016. ,
Gene profiling predicts rheumatoid arthritis responsiveness to IL-1Ra (anakinra), Rheumatology (Oxford), vol.50, issue.2, pp.283-92, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02329564
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis, Arthritis Res Ther, vol.8, issue.4, p.105, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00089669
Prediction of treatment response to adalimumab: a doubleblind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis, Pharmacogenomics J, vol.16, issue.2, pp.141-147, 2015. ,
Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood mononuclear cells using genome-wide DNA microarray, Arthritis Rheum, vol.66, issue.6, pp.1421-1452, 2014. ,
Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial, Arthritis Rheum, vol.66, issue.8, pp.2015-2040, 2014. ,
Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study, RMD Open, vol.2, issue.1, p.237, 2016. ,
Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study, Ann Rheum Dis, vol.75, issue.10, pp.1763-1772, 2016. ,
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, vol.31, issue.3, pp.315-339, 1988. ,
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score, Ann Rheum Dis, vol.49, issue.11, pp.916-936, 1990. ,
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol, vol.3, issue.7, p.34, 2002. ,
Positivity for rheumatoid factor and anti-cyclic citrullinated peptide is associated with a better drug retention of abatacept: data from a pan European analysis of RA registries, Ann Rheum Dis, vol.73, issue.2, pp.502-505, 2014. ,
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry, Ann Rheum Dis, vol.71, issue.11, pp.1815-1824, 2012. ,
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study, BMC Musculoskelet Disord, vol.16, p.176, 2015. ,
Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis, J Rheumatol, vol.38, issue.10, pp.2105-2116, 2011. ,
Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis, PLoS One, vol.7, issue.3, p.33199, 2012. ,
Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients, Mod Rheumatol, vol.23, issue.4, pp.729-769, 2012. ,
Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study, Arthritis Res Ther, vol.18, p.159, 2016. ,
Ribonuclease III, mechanisms of double-stranded RNA cleavage, Wiley Interdiscip Rev RNA, vol.5, issue.1, pp.31-48, 2013. ,
Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1, Biochem J, vol.443, issue.3, pp.655-61, 2012. ,
Novel insights into the assembly and function of human nuclear-encoded cytochrome c oxidase subunits 4, 5a, 6a, 7a and 7b, Biochem J, vol.428, issue.3, pp.363-74, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00486858
Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells, Cell Death Dis, vol.5, p.1540, 2014. ,
T cells: Mitochondria and T cell activation, Nat Rev Immunol, vol.13, issue.4, p.224, 2013. ,
Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling, Immunity, vol.38, issue.2, pp.225-261, 2013. ,
Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression, J Exp Med, vol.195, issue.1, pp.59-70, 2002. ,
Mitochondria are gate-keepers of T cell function by producing the ATP that drives purinergic signaling, J Biol Chem, vol.289, issue.37, pp.25936-25981, 2014. ,
Mitochondrial formation of reactive oxygen species, J Physiol, vol.552, issue.2, pp.335-379, 2003. ,
CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells, Arthritis Rheum, vol.54, issue.10, pp.3135-3178, 2006. ,
Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytes, J Immunol, vol.173, issue.2, pp.920-951, 2004. ,
Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria, J Pathol, vol.230, issue.4, pp.410-419, 2013. ,
Over-expression of the ATP5J gene correlates with cell migration and 5-fluorouracil sensitivity in colorectal cancer, PLoS One, vol.8, issue.10, p.76846, 2013. ,
Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy, Science, vol.334, issue.6059, pp.1129-1162, 2011. ,